OSAKA, Japan & CAMBRIDGE, Mass. (BUSINESS WIRE) Takeda (TSE:4502/NYSE:TAK) today announced that it has completed an acquisition of all shares of Nimbus La
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Takeda to acquire Nimbus TYK2 inhibitor in deal worth $6bn pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - Takeda Pharmaceutical said on Tuesday it would acquire Nimbus Therapeutics' experimental inflammatory disease treatment for $4 billion in .